Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
about
Autonomic responses to exercise: group III/IV muscle afferents and fatigue.Oral antioxidants improve leg blood flow during exercise in patients with chronic obstructive pulmonary disease.Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitanceVentilation Increases with Lower Extremity Venous Occlusion in Young Adults.Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fractionGroup III/IV locomotor muscle afferents alter motor cortical and corticospinal excitability and promote central fatigue during cycling exercise.The Mechanoreflex and Hemodynamic Response to Passive Leg Movement in Heart FailureTemporal changes in the exercise pressor reflex in type 1 diabetic rats.Neural Contributions to Muscle Fatigue: From the Brain to the Muscle and Back Again.V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents.Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.Spinal μ-opioid receptor-sensitive lower limb muscle afferents determine corticospinal responsiveness and promote central fatigue in upper limb muscle.Intrathecal fentanyl abolishes the exaggerated blood pressure response to cycling in hypertensive men.Muscle metaboreflex and cerebral blood flow regulation in humans: implications for exercise with blood flow restriction.Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training.Revisiting the Physiological Effects of Exercise Training on Autonomic Regulation and Chemoreflex Control in Heart Failure: Does Ejection Fraction Matter?Central and peripheral hemodynamics in exercising humans: leg vs arm exercise.
P2860
Q35108132-EAAC4CEF-59A6-48FB-82ED-A7482DA70B38Q36114305-96213C8C-BB32-4D10-A1B4-219E77D24AD9Q36157352-533C4A46-7AA7-4E9A-B960-4233635674D2Q36599031-0FB4E705-AA32-4C24-B6BE-4CBD00E7BFEEQ36805655-3303515E-60C8-4957-B6A3-0AF10252577FQ37589344-1ADCBFB9-CDA4-44FB-A5AE-B5A27AB0D4C0Q38570830-CB4BE180-5039-4DC5-8D16-8F55BF4E31E5Q38639851-787D6A1F-EBBE-481F-9EC9-FFA524AB1BBFQ38785028-F6AC511C-9163-4194-99A6-2B07EE112251Q38801305-D32913D1-A8FA-4CE2-AB03-D9DCDA405585Q38890471-8A6F8CEE-3800-4154-828E-AC3182691355Q44346806-49DD4B60-D30C-4AA7-90D0-3CB52E286B4FQ47616949-2D2C9EC6-7773-4F2B-BF01-F48F0B7EEBBFQ48044249-C7EAC66F-C542-498C-BBC1-EA8BB30FFBDDQ49488565-64C23D0D-6B57-4BC8-A537-2BBE32388FF8Q49789531-2156EE0A-4BDE-48B9-B648-1F1B7CE2DD52Q50238848-793A47A8-95E7-46E7-9BD2-999CA57DF97E
P2860
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@ast
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@en
type
label
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@ast
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@en
prefLabel
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@ast
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@en
P2093
P2860
P50
P1476
Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
@en
P2093
Benjamin Gmelch
D Walter Wray
David E Morgan
H Jonathan Groot
Melissa A H Witman
Russell S Richardson
Stephen J Ives
P2860
P304
P356
10.1016/J.IJCARD.2014.04.157
P577
2014-04-21T00:00:00Z